These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 2858538)
1. In-vivo metabolism in the rat and mouse of antrafenine to 1-m-trifluoromethylphenylpiperazine. Caccia S; Conti I; Notarnicola A J Pharm Pharmacol; 1985 Jan; 37(1):75-7. PubMed ID: 2858538 [TBL] [Abstract][Full Text] [Related]
2. A kinetic study of the fate of SL 73033 (antrafenine) in the rat [proceedings]. Dring LG; Durand A; Gomeni R; Mas-Chamberlain C Br J Pharmacol; 1978 Jun; 63(2):368P. PubMed ID: 667447 [No Abstract] [Full Text] [Related]
3. [Pharmacokinetics of antrafenine after a single dose in the young adult]. Rovei V; Broquaire M; Tedeschi G; Thebault JJ; Sauvanet JP; Larribaud J Therapie; 1980; 35(4):551-2. PubMed ID: 7466734 [No Abstract] [Full Text] [Related]
4. 1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat. Caccia S; Conti I; Viganò G; Garattini S Pharmacology; 1986; 33(1):46-51. PubMed ID: 2874572 [TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of antrafenine after single and repeated administration in aged patients]. Sauvanet JP; Rovei V; Guinebault P; Trocherie S; Memin Y; Gomeni R; Braithwaite RA; Venet R Therapie; 1980; 35(4):552-4. PubMed ID: 7466735 [No Abstract] [Full Text] [Related]
6. Metabolism of a new analgesic agent, dl-erythro-1-phenyl-2-(o-chlorophenyl)-2-[4-(p-methoxybenzyl)-1-piperazinyl]ethanol dihydrochloride, in rats. Hashimoto M; Sekine Y; Muto J; Yamaguchi T; Maeda T; Utsui Y; Yoshida K; Arakawa S; Shimokawa N; Shimakawa K Drug Metab Dispos; 1979; 7(6):435-41. PubMed ID: 43234 [No Abstract] [Full Text] [Related]
7. [Comparative pharmacokinetics of antrafenine in healthy volunteers and in patients with chronic renal failure (author's transl)]. Rovei V; Leroy A; Sauvanet JP; Braithwaite R; Coquelin JP; Gomeni R; Morselli PL; Fillastre JP Therapie; 1981; 36(1):21-6. PubMed ID: 7233368 [No Abstract] [Full Text] [Related]
8. [Pharmacokinetics and biotransformation of the analgesic flupirtine in the rat and dog]. Obermeier K; Niebch G; Thiemer K Arzneimittelforschung; 1985; 35(1):60-7. PubMed ID: 4039153 [TBL] [Abstract][Full Text] [Related]
9. Metabolic fate of the novel antihypertensive drug naftopidil. Niebch G; Locher M; Peter G; Borbe HO Arzneimittelforschung; 1991 Oct; 41(10):1027-32. PubMed ID: 1665973 [TBL] [Abstract][Full Text] [Related]
10. Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SNC121 in rats. Schetz JA; Calderon SN; Bertha CM; Rice K; Porreca F J Pharmacol Exp Ther; 1996 Dec; 279(3):1069-76. PubMed ID: 8968326 [TBL] [Abstract][Full Text] [Related]
11. Effect of dosage and route of administration of trazodone on cerebral concentration of 1-m-chlorophenylpiperazine in rats. Kinetics of trazodone biotransformation in rats. Rurak A; Melzacka M Pol J Pharmacol Pharm; 1983; 35(3):241-7. PubMed ID: 6622303 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of 4-(3-cyclohexylpropionyl)-1-(2-ethoxyphenyl) piperazine (D-16120) by rat liver microsomes. Caputo O; Rocco F; Grosa G Eur J Drug Metab Pharmacokinet; 1994; 19(4):303-10. PubMed ID: 7737231 [TBL] [Abstract][Full Text] [Related]
13. Biotransformation of urapidil: isolation and identification of metabolites in mouse, rat, dog and man. Sturm E; Zech K Biomed Mass Spectrom; 1984 May; 11(5):211-6. PubMed ID: 6743765 [TBL] [Abstract][Full Text] [Related]
14. Disposition of the psychotropic drugs buspirone, MJ-13805 and piribedil, and of their common active metabolite 1-(2-pyrimidinyl)-piperazine in the rat. Caccia S; Fong MH; Guiso G Xenobiotica; 1985 Oct; 15(10):835-44. PubMed ID: 2866634 [TBL] [Abstract][Full Text] [Related]
15. Determination of antrafenine and its main acid metabolite, 2-{[7-(trifluoromethyl)-4-quinolinyl]amino}-benzoic acid, in biological fluids using high-performance liquid chromatography with large volume automatic injection and gas-liquid chromatography with derivative formation. Guinebault PR; Broquaire M; Sanjuan M; Rovei V; Braithwaite RA J Chromatogr; 1981 Apr; 223(1):103-10. PubMed ID: 7251752 [TBL] [Abstract][Full Text] [Related]
16. Terminal N-sulphoconjugation of an alicyclic amine (piperazine), identified as a new metabolite of tiaramide in mouse and rat. Iwasaki K; Shiraga T; Noda K; Tada K; Noguchi H Xenobiotica; 1983 May; 13(5):273-8. PubMed ID: 6636823 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Csanády GA; Guengerich FP; Bond JA Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680 [TBL] [Abstract][Full Text] [Related]
19. The effects of SKF 525-A on the analgesic and barbiturate-potentiating activity of delta 9-tetrahydrocannabinol in mice and rats. Sofia RD; Barry H Pharmacology; 1983; 27(4):223-36. PubMed ID: 6314397 [TBL] [Abstract][Full Text] [Related]
20. Enterohepatic circulation in rat and dog of 14C-0-[3-(4-less than 2-methoxyphenyl greater than-1-piperazinyl)-2-hydroxypropyl]-3-methoxy-benzaldoxim dihydrochloride and it's demethylated metabolite. Paul H; Illing A; House ES Eur J Drug Metab Pharmacokinet; 1981; 6(4):303-12. PubMed ID: 7333331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]